Heart Failure in African American Individuals, Version 2.0

Clyde W Yancy^{1

2}

Affiliations

¹ Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
² Deputy Editor, JAMA Cardiology.

Editorial

Clyde W Yancy. JAMA. 2024.

. 2024 Jun 4;331(21):1807-1808.

doi: 10.1001/jama.2024.5217.

Clyde W Yancy^{1

2}

¹ Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
² Deputy Editor, JAMA Cardiology.

No abstract available

Comment in

Addressing Health Disparities-The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger.
Maurer MS, Miller EJ, Ruberg FL. Maurer MS, et al. JAMA. 2024 Jun 4;331(21):1809-1811. doi: 10.1001/jama.2024.2868. JAMA. 2024. PMID: 38734953 No abstract available.

Cardiovascular Burden of the V142I Transthyretin Variant.
Selvaraj S, Claggett B, Shah SH, Mentz RJ, Khouri MG, Manichaikul AW, Khan SS, Rich SS, Mosley TH, Levitan EB, Arora P, Goyal P, Haring B, Eaton CB, Cheng RK, Wells GL, Manson JE, Fontana M, Solomon SD. Selvaraj S, et al. JAMA. 2024 Jun 4;331(21):1824-1833. doi: 10.1001/jama.2024.4467. JAMA. 2024. PMID: 38734952 Free PMC article.
Addressing Health Disparities-The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger.
Maurer MS, Miller EJ, Ruberg FL. Maurer MS, et al. JAMA. 2024 Jun 4;331(21):1809-1811. doi: 10.1001/jama.2024.2868. JAMA. 2024. PMID: 38734953 No abstract available.